Protara Therapeutics Inc (NASDAQ:TARA)’s traded shares stood at 0.34 million during the last session, with the company’s beta value hitting 1.71. At the close of trading, the stock’s price was $3.74, to imply an increase of 10.32% or $0.35 in intraday trading. The TARA share’s 52-week high remains $10.48, putting it -180.21% down since that peak but still an impressive 57.22% since price per share fell to its 52-week low of $1.60.
Analysts have given a consensus recommendation of Buy for Protara Therapeutics Inc (TARA), translating to a mean rating of 1.00. Of 1 analyst(s) looking at the stock, 0 analyst(s) give TARA a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 1 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.56.
Protara Therapeutics Inc (NASDAQ:TARA) trade information
After registering a 10.32% upside in the last session, Protara Therapeutics Inc (TARA) has traded red over the past five days. The 5-day price performance for the stock is 0.54%, and -17.26% over 30 days. With these gigs, the year-to-date price performance is -29.17%.
An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 39.98% for the past 5-year period. While 2025 is set for a 38.38% return in earnings, projections for the next 5 years are at 15.23% annually.
TARA Dividends
Protara Therapeutics Inc has its next earnings report out in April. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
The next major institution holding the largest number of shares is RA CAPITAL MANAGEMENT, L.P. with 1.9 million shares, or about 16.6361% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $3.95 million.
We also have Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the Protara Therapeutics Inc (TARA) shares. Going by data provided on Sep 30, 2024 , Vanguard Total Stock Market Index Fund holds roughly 616.3 shares. This is just over 2.99% of the total shares, with a market valuation of $2.3 million. Data from the same date shows that the other fund manager holds a little less at 140.67, or 0.68% of the shares, all valued at about 0.53 million.
